DE3684514D1 - Verwendung von penicillamin zur behandlung von immunmangelkrankheiten. - Google Patents

Verwendung von penicillamin zur behandlung von immunmangelkrankheiten.

Info

Publication number
DE3684514D1
DE3684514D1 DE8686106646T DE3684514T DE3684514D1 DE 3684514 D1 DE3684514 D1 DE 3684514D1 DE 8686106646 T DE8686106646 T DE 8686106646T DE 3684514 T DE3684514 T DE 3684514T DE 3684514 D1 DE3684514 D1 DE 3684514D1
Authority
DE
Germany
Prior art keywords
penicillamine
treatment
isomer
htlv
aids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686106646T
Other languages
German (de)
English (en)
Inventor
Prakash Prof Dr Phil Chandra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chandra Prakash Prof Drphilnat 60489 Frankf
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Priority to DE8686106646T priority Critical patent/DE3684514D1/de
Application granted granted Critical
Publication of DE3684514D1 publication Critical patent/DE3684514D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8686106646T 1985-06-08 1986-05-15 Verwendung von penicillamin zur behandlung von immunmangelkrankheiten. Expired - Lifetime DE3684514D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE8686106646T DE3684514D1 (de) 1985-06-08 1986-05-15 Verwendung von penicillamin zur behandlung von immunmangelkrankheiten.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3520624 1985-06-08
DE8686106646T DE3684514D1 (de) 1985-06-08 1986-05-15 Verwendung von penicillamin zur behandlung von immunmangelkrankheiten.

Publications (1)

Publication Number Publication Date
DE3684514D1 true DE3684514D1 (de) 1992-04-30

Family

ID=6272806

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686106646T Expired - Lifetime DE3684514D1 (de) 1985-06-08 1986-05-15 Verwendung von penicillamin zur behandlung von immunmangelkrankheiten.

Country Status (8)

Country Link
US (1) US4847297A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0204989B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS61286325A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE73995T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU584551B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1283859C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3684514D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA864263B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192788A (en) * 1988-05-23 1993-03-09 Georgia State University Foundation, Inc. Porphyrin antiviral compositions
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
US5554655A (en) * 1991-09-30 1996-09-10 Jess G. Thoene Method of treating HIV infection
MX9205549A (es) * 1991-09-30 1993-05-01 Jess G Thoene Metodo para el tratamiento de vih.
US6764693B1 (en) 1992-12-11 2004-07-20 Amaox, Ltd. Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants
US5725870A (en) * 1993-10-15 1998-03-10 Thoene; Jess G. Methods, composites and articles for contraception
EP0789565A4 (en) * 1993-10-15 1999-03-24 Jess G Thoene PREVENTION OF HIV INFECTION
US6117904A (en) * 1999-09-03 2000-09-12 Murphy; Donald M. Treatment of pruritus
US6541517B1 (en) * 1999-09-03 2003-04-01 Donald M. Murphy Treatment of skin disorders
US20070134277A1 (en) * 2005-12-09 2007-06-14 Children's Medical Center Corporation Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms
US20100166833A1 (en) * 2007-05-07 2010-07-01 Technion Research & Development Foundation Ltd. Compositions, articles and methods for preventing or reducing tobacco-associated damage
US20190282519A1 (en) * 2018-03-19 2019-09-19 Cronus Research Labs Private Limited Pencillamine oral composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB585413A (en) * 1944-06-19 1947-02-06 Wellcome Found Improved method for the resolution of penicillamine
GB1424432A (en) * 1972-03-25 1976-02-11 Degussa Pharmaceutical compositions
CH588887A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1974-07-19 1977-06-15 Battelle Memorial Institute
US4487780A (en) * 1979-09-18 1984-12-11 Scheinberg Israel H Method of treatment of rheumatoid arthritis

Also Published As

Publication number Publication date
EP0204989A3 (en) 1989-12-20
ZA864263B (en) 1987-02-25
EP0204989B1 (de) 1992-03-25
EP0204989A2 (de) 1986-12-17
US4847297A (en) 1989-07-11
CA1283859C (en) 1991-05-07
ATE73995T1 (de) 1992-04-15
JPS61286325A (ja) 1986-12-16
JPH0380772B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-12-26
AU5844086A (en) 1986-12-11
AU584551B2 (en) 1989-05-25

Similar Documents

Publication Publication Date Title
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
DE3684514D1 (de) Verwendung von penicillamin zur behandlung von immunmangelkrankheiten.
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
NL950022I2 (nl) Analoga van mevalolacton en derivaten daarvan, werkwijzen voor hun bereiding, farmaceutische prepar aten die ze bevatten en hun toepassing als farmaceutica.
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
MD1507G2 (ro) Inhibitori, compoziţie farmaceutică pe baza lor şi procedeu de inhibare a HIV proteazei
ATE184193T1 (de) Verwendung von n-acylaminoalkoholen zur herstellung eines arzneimittels zur behandlung von mastzellerkrankungen
DE59106133D1 (de) Feste, schnell-lösliche Arzneimittelzubereitung enthaltend S-(Carboxymethyl)-L-Cystein und/oder N-Acetylcystein.
GR3017128T3 (en) Treatment of hiv infections and compounds useful therein.
RU94046093A (ru) Производные 7-(2-аминоэтил)бензотиазолона, способ их получения, промежуточные соединения, фармкомпозиция
AU563215B2 (en) Sterilizable storage solution for red blood cells
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
ATE135223T1 (de) Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose
ATE55248T1 (de) Arzneimittelkombination.
EP0354568A3 (en) Novel catechol derivatives
DE3856052D1 (de) Anwendung des N-n-butyl-Derivates von Desoxynojirimycin zur Herstellung eines Arzneimittels zur Inhibierung von HIV-Virus
DK248886D0 (da) Spiro-imidazolidin-forbindelser og farmaceutiske praeparater indeholdende disse
ATE26841T1 (de) Verbindungen zur behandlung von erhoehtem blutdruck.
DE69419954D1 (de) Arzneimittel zur Behandlung von Hauterkrankungen
NO165393C (no) Fremgansmaate for fremstilling av aryloksypropanolaminer og salter av disse med difenyleddiksyre.
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
FR2658190B1 (fr) Esters d'aminoacides de l'hydroquinone, leur procede de preparation et compositions pharmaceutiques ou cosmetiques les contenant.
DE3773059D1 (de) Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.
BG60236B1 (bg) Метод за получаване на цикличен пропиленов естер на дихидропиридин-5-фосфонова киселина

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASTA MEDICA AG, O-8020 DRESDEN, DE

8327 Change in the person/name/address of the patent owner

Owner name: CHANDRA, PRAKASH, PROF. DR.PHIL.NAT., 60489 FRANKF

8339 Ceased/non-payment of the annual fee